Rosemont Pharmaceuticals acquired by US giant for £180m

YORKSHIRE-BASED pharmaceuticals manufacturer Rosemont has been sold by its private equity owner to a listed US group in a deal worth £180m.

The sees Leeds firm Rosemont Pharmaceuticals sold by CBPE Capital to Perrigo Company, a $10bn US group. Its management team will remain in place under the new owner.

CBPE acquired Rosemont in August 2006 for £93m. The sale to Perrigo represents an investment multiple of 3.25 times CBPE’s £52m equity investment over the investment period.

Rosemont develops, manufactur... For the full story register now for free or login below...

Close